J Rheum Dis.  2011 Sep;18(3):187-192. 10.4078/jrd.2011.18.3.187.

Survey of Current Trends for Diagnosis and Treatment in Korean Gout Patients

• Seo YI
• Son KM
• Jung YO
• Kim IJ
• Kim KL
• Bae YD
• Kim HA

• KMID: 2223148
• DOI: http://doi.org/10.4078/jrd.2011.18.3.187

Abstract

OBJECTIVE
The prevalence of gout has increased so accurate diagnosis and constant treatment is important in its management. The purpose this study was to examine the current trends in the diagnosis and treatment of gout patients in Korea.
METHODS
We enrolled patients who were diagnosed as having gout and received treatment in university hospital between 2005 and 2008. From the survey, we assessed and analyzed the patient's baseline characteristics, clinical aspects of gout attack, medical institution and specialized department in the first gouty attack, medical institution and specialized department where the gout was initially diagnosed, methods of diagnosis, treatment during gout attack, and knowledge about gout in patients.
RESULTS
A total of 136 patients were included in this study, out of which 123 (90.4%) were male and the mean age was 55.2 (range 25~85) years. When patients experienced the first gout attack, the most common medical institution that they attended was a private clinic and the most common specialized department was orthopedics. Medication by oral route was the major method (80.9%) used for the treatment of gout, and the most common medication was a non-steroidal anti-inflammatory drug (NSAID) in 55.9%, allopurinol in 38.2% and colchicine in 20.6% of patients. Many gout patients inappropriately received allopurinol following signs of gout arthritis attack, with little information specifically about gout.
CONCLUSION
In our survey, many gout patients received inadequate medications for the treatment of gout and had little knowledge about the disease. For the adequate treatment of gout, patients and doctors need to be educated sufficiently.

Keyword

Gout; Treatment; Education; Survey

MeSH Terms

Allopurinol
Arthritis
Colchicine
Gout
Humans
Male
Orthopedics
Prevalence
Allopurinol
Colchicine

Reference

References

1. Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol. 2003; 30:2245–51.

2. Lee CH, Sung NY. The Prevalence and Features of Korean Gout Patients Using the National Health Insu-rance Corporation Database. J Rheum Dis. 2011; 18:94–100.

3. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977; 20:895–900.

4. Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. Prevalence of the metabolic syndrome in patients with gout. J Korean Rheum Assoc. 2004; 11:349–57.

5. Schlesinger N, Moore DF, Sun JD, Schumacher HR Jr. A survey of current evaluation and treatment of gout. J Rheumatol. 2006; 33:2050–2.

6. Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol. 2006; 33:104–9.

7. Riedel AA, Nelson M, Joseph-Ridge N, Wallace K, MacDonald P, Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004; 31:1575–81.

8. Son KM, Seo YI, Kim IJ, Bae YD, Jung YO, Cha MJ, et al. Adherence to uric acid lowering agent of gouty patients. J Korean Rheum Assoc. 2010; 17:162–7.

9. Kim EH, Jeon K, Park KW, Kim HJ, Ahn JK, Jeon CH, et al. The prevalence of gout among hyperuricemic population. J Korean Rheum Assoc. 2004; 11:7–13.

10. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis. 2005; 64:267–72.